Haro A - Search Results

1

Cannabinoids and ceramide: two lipids acting hand-by-hand.

Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Haro A, Guzmán M. Velasco G, et al. Among authors: haro a. Life Sci. 2005 Aug 19;77(14):1723-31. doi: 10.1016/j.lfs.2005.05.015. Life Sci. 2005. PMID: 15958274 Review.

2

De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis.

Gómez del Pulgar T, Velasco G, Sánchez C, Haro A, Guzmán M. Gómez del Pulgar T, et al. Among authors: haro a. Biochem J. 2002 Apr 1;363(Pt 1):183-8. doi: 10.1042/0264-6021:3630183. Biochem J. 2002. PMID: 11903061 Free PMC article.

3

Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.

Blázquez C, González-Feria L, Alvarez L, Haro A, Casanova ML, Guzmán M. Blázquez C, et al. Among authors: haro a. Cancer Res. 2004 Aug 15;64(16):5617-23. doi: 10.1158/0008-5472.CAN-03-3927. Cancer Res. 2004. PMID: 15313899

4

Cannabinoids and gliomas.

Velasco G, Carracedo A, Blázquez C, Lorente M, Aguado T, Haro A, Sánchez C, Galve-Roperh I, Guzmán M. Velasco G, et al. Among authors: haro a. Mol Neurobiol. 2007 Aug;36(1):60-7. doi: 10.1007/s12035-007-0002-5. Epub 2007 Jun 28. Mol Neurobiol. 2007. PMID: 17952650 Review.

5

Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.

Blázquez C, Salazar M, Carracedo A, Lorente M, Egia A, González-Feria L, Haro A, Velasco G, Guzmán M. Blázquez C, et al. Among authors: haro a. Cancer Res. 2008 Mar 15;68(6):1945-52. doi: 10.1158/0008-5472.CAN-07-5176. Cancer Res. 2008. PMID: 18339876

6

Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?

Blázquez C, Carracedo A, Salazar M, Lorente M, Egia A, González-Feria L, Haro A, Velasco G, Guzmán M. Blázquez C, et al. Among authors: haro a. Neuropharmacology. 2008 Jan;54(1):235-43. doi: 10.1016/j.neuropharm.2007.06.021. Epub 2007 Jul 1. Neuropharmacology. 2008. PMID: 17675107 Clinical Trial.

7

Ceramide-induced translocation of protein kinase C zeta in primary cultures of astrocytes.

Galve-Roperh I, Haro A, Díaz-Laviada I. Galve-Roperh I, et al. Among authors: haro a. FEBS Lett. 1997 Oct 6;415(3):271-4. doi: 10.1016/s0014-5793(97)00985-x. FEBS Lett. 1997. PMID: 9357981 Free article.

8

Induction of nerve growth factor synthesis by sphingomyelinase and ceramide in primary astrocyte cultures.

Galve-Roperh I, Haro A, Díaz-Laviada I. Galve-Roperh I, et al. Among authors: haro a. Brain Res Mol Brain Res. 1997 Dec 1;52(1):90-7. doi: 10.1016/s0169-328x(97)00230-1. Brain Res Mol Brain Res. 1997. PMID: 9450681

9

Evidence for the lack of involvement of sphingomyelin hydrolysis in the tumor necrosis factor-induced secretion of nerve growth factor in primary astrocyte cultures.

Galve-Roperh I, Sánchez C, Ségui B, Haro A, Díaz-Laviada I, Levade T. Galve-Roperh I, et al. Among authors: haro a. J Neurochem. 1998 Aug;71(2):498-505. doi: 10.1046/j.1471-4159.1998.71020498.x. J Neurochem. 1998. PMID: 9681439 Free article.

10

The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase.

Rueda D, Galve-Roperh I, Haro A, Guzmán M. Rueda D, et al. Among authors: haro a. Mol Pharmacol. 2000 Oct;58(4):814-20. doi: 10.1124/mol.58.4.814. Mol Pharmacol. 2000. PMID: 10999952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page